Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderate-to-severe atopic dermatitis
Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderat…
Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderat…
Diabetes is of primarily two types – Diabete mellitus (Type-I and Type II) and Diabet…
“The Right of Persons with Disabilities bill- 2016” was passed by both houses Rajya S…
Inviting applications for various post under Integrated Disease Surveillance Proje…
“Recurrent headaches…sleepless nights…pale skin…lack of concentration….extra pou…
Public Health Initiatives by Takeda to Strengthen Health System for Rare Diseases i…
PREMIUM JOBS Programme Manager - Survivors’ Leadership Program Kamonohashi Project…